Aleena Shahnawaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Aleena Shahnawaz has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Abhinav Singla
Division of Hospital Internal Medicine, Mayo Clinic, Jacksonville, FL, USA
1 shared publication - Aleksandra Murawska Baptista
Division of Hospital Internal Medicine, Mayo Clinic, Jacksonville, FL, USA
1 shared publication - Alyssa Catherine Raj
Pozna? University of Medical Sciences, Pozna?, Poland
1 shared publication Anam Sadia
Department of Internal Medicine, Fatima Jinnah Medical University, Lahore, Pakistan
1 shared publication- Asmita Addanki
Pozna? University of Medical Sciences, Pozna?, Poland
1 shared publication - Muhammad Ali
Department of Hospital Internal Medicine, Mayo Clinic, Jacksonville, USA
1 shared publication
Latest Publications
- Open Access
- 12 February 2026
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 27, e951331
Bilateral Adrenal Infarction as an Uncommon Complication of Heparin-Induced Thrombocytopenia: A Case Report
BACKGROUND Heparin-induced thrombocytopenia (HIT) is an immune-mediated reaction that occurs 5-10 days after heparin exposure. Antibodies against platelet factor 4 (PF4) activate platelets and lead to a hypercoagulable state, causing thrombotic complications, including deep venous thrombosis, pulmonary embolism, stroke, and myocardial infarction. Given the widespread use of prophylactic heparin in clinical practice, prompt recognition and management are crucial due to the associated high morbidity and mortality. CASE REPORT A 73-year-old woman with hypertension, hypothyroidism, depression, and anxiety presented with 6 days of nausea, vomiting, abdominal pain, constipation, weakness, and postural dizziness. She recently underwent cervical spine surgery and received prophylactic heparin. Laboratory findings showed normocytic anemia, mild leukocytosis, new-onset thrombocytopenia, and hyponatremia. Further evaluation revealed low morning cortisol, positive PF4 antibodies, and serotonin release assay (SRA), consistent with HIT. CT demonstrated bilateral adrenal enlargement and peripheral fat stranding, confirming adrenal infarction. Discontinuation of heparin and treatment with rivaroxaban, intravenous steroids, and hemodynamic support led to significant improvement. CONCLUSIONS HIT-induced adrenal infarction is uncommon and often overlooked due to its nonspecific presentation. This case emphasizes the importance of suspecting adrenal involvement in patients with prior heparin exposure and hypotension or electrolyte imbalance. Prompt anticoagulant adjustment, steroid replacement, and follow-up with hemodynamic monitoring can improve clinical outcomes.
- 12 February 2026
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 27, e951331
Open AccessBilateral Adrenal Infarction as an Uncommon Complication of Heparin-Induced Thrombocytopenia: A Case Report
BACKGROUND Heparin-induced thrombocytopenia (HIT) is an immune-mediated reaction that occurs 5-10 days after heparin exposure. Antibodies against platelet factor 4 (PF4) activate platelets and lead to a hypercoagulable state, causing thrombotic complications, including deep venous thrombosis, pulmonary embolism, stroke, and myocardial infarction. Given the widespread use of prophylactic heparin in clinical practice, prompt recognition and management are crucial due to the associated high morbidity and mortality. CASE REPORT A 73-year-old woman with hypertension, hypothyroidism, depression, and anxiety presented with 6 days of nausea, vomiting, abdominal pain, constipation, weakness, and postural dizziness. She recently underwent cervical spine surgery and received prophylactic heparin. Laboratory findings showed normocytic anemia, mild leukocytosis, new-onset thrombocytopenia, and hyponatremia. Further evaluation revealed low morning cortisol, positive PF4 antibodies, and serotonin release assay (SRA), consistent with HIT. CT demonstrated bilateral adrenal enlargement and peripheral fat stranding, confirming adrenal infarction. Discontinuation of heparin and treatment with rivaroxaban, intravenous steroids, and hemodynamic support led to significant improvement. CONCLUSIONS HIT-induced adrenal infarction is uncommon and often overlooked due to its nonspecific presentation. This case emphasizes the importance of suspecting adrenal involvement in patients with prior heparin exposure and hypotension or electrolyte imbalance. Prompt anticoagulant adjustment, steroid replacement, and follow-up with hemodynamic monitoring can improve clinical outcomes.